Bruker (NASDAQ:BRKR) Hits New 1-Year Low - Here's What Happened

Shares of Bruker Co. (NASDAQ:BRKR - Get Free Report) reached a new 52-week low on Thursday . The stock traded as low as $39.88 and last traded at $41.15, with a volume of 2206068 shares changing hands. The stock had previously closed at $40.38.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Barclays cut their target price on Bruker from $69.00 to $65.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. UBS Group assumed coverage on shares of Bruker in a research note on Tuesday, December 10th. They issued a "neutral" rating and a $66.00 target price on the stock. Stifel Nicolaus lowered their target price on shares of Bruker from $70.00 to $57.00 and set a "hold" rating on the stock in a report on Friday, February 14th. Bank of America boosted their price target on shares of Bruker from $78.00 to $80.00 and gave the company a "buy" rating in a research report on Friday, December 13th. Finally, Citigroup dropped their price objective on shares of Bruker from $75.00 to $50.00 and set a "buy" rating for the company in a report on Monday. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Bruker has an average rating of "Moderate Buy" and an average price target of $68.00.

Bruker Price Performance

The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of 50.92, a PEG ratio of 2.16 and a beta of 1.18. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. The company has a 50 day moving average price of $48.29 and a 200 day moving average price of $55.79.

Remove Ads

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping analysts' consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, equities research analysts forecast that Bruker Co. will post 2.69 earnings per share for the current year.

Bruker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Monday, March 17th were paid a $0.05 dividend. The ex-dividend date of this dividend was Monday, March 17th. This represents a $0.20 dividend on an annualized basis and a yield of 0.52%. Bruker's payout ratio is presently 26.32%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Eagle Bay Advisors LLC boosted its holdings in Bruker by 2,324.1% during the fourth quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company's stock worth $41,000 after buying an additional 674 shares during the last quarter. UMB Bank n.a. boosted its stake in Bruker by 37.5% during the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock worth $53,000 after acquiring an additional 248 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in Bruker by 274.9% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,091 shares of the medical research company's stock valued at $46,000 after purchasing an additional 800 shares in the last quarter. Quadrant Capital Group LLC increased its stake in Bruker by 18.2% in the fourth quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company's stock valued at $75,000 after purchasing an additional 196 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Bruker by 47.5% during the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company's stock worth $75,000 after purchasing an additional 412 shares in the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.